Chemoinformaics analysis of isovaleric acid-ester
| Molecular Weight | 369.609 | nRot | 8 |
| Heavy Atom Molecular Weight | 349.449 | nRig | 2 |
| Exact Molecular Weight | 368.011 | nRing | 0 |
| Solubility: LogS | -2.864 | nHRing | 0 |
| Solubility: LogP | 3.217 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 45.8859 |
| nHD | 0 | BPOL | 36.3781 |
| QED | 0.357 |
| Synth | 3.615 |
| Natural Product Likeliness | 0.196 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.904 |
| MDCK | 0.000100841 |
| BBB | 0.954 |
| PPB | 0.642585 |
| VDSS | 0.77 |
| FU | 0.249601 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.331 |
| CYP2c19-inh | 0.286 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.206 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.298 |
| CYP3a4-inh | 0.132 |
| CYP3a4-sub | 0.866 |
| CL | 1.945 |
| T12 | 0.811 |
| hERG | 0.009 |
| Ames | 0.454 |
| ROA | 0.024 |
| SkinSen | 0.239 |
| Carcinogencity | 0.034 |
| EI | 0.453 |
| Respiratory | 0.31 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.710672 |